WEBULL
WebtradeDownload

Perrigo (PRGO) Rebounds As Self Care Demand Narrative Points To Undervalued Shares

Simply Wall St · 1d ago

Perrigo (PRGO) has drawn fresh attention after recent share price moves coupled with mixed return patterns, including a gain over the past 3 months but a decline over the past year. That combination invites closer inspection.

Recent trading hints at shifting sentiment around Perrigo. The latest share price of $13.56 sits against a 90 day share price return of 32.29%, even as the 1 year total shareholder return has fallen 30.21%. This suggests that short term momentum is building while longer term holders remain under pressure.

Scan how Perrigo's recent rebound compares with other under-pressure healthcare names by reviewing a curated group of 16 high quality undiscovered gems.

Perrigo has rebounded sharply over 3 months while longer term returns remain weak. Do you lean into the recovery now, or wait for a cheaper entry before the valuation work stacks up for you?

Most Popular Narrative: 18% Undervalued

Perrigo is priced at $13.56 against a widely followed fair value estimate of $16.50, so the narrative leans toward meaningful upside if execution roughly matches expectations.

The aging global population and rising consumer interest in self-care and wellness continue to create longer-term demand tailwinds for Perrigo's OTC and nutrition products, providing stable, defensive revenue streams even in periods of macro uncertainty.

See why 13 investors see Perrigo as 18% undervalued.

Result: Fair Value of $16.50 (UNDERVALUED)

Still, the Perrigo story carries real pressure points, including ongoing losses of US$1.7b and soft category demand that could keep revenue and margins under strain.

Find out about the key risks to this Perrigo narrative.

Next Steps

Feeling torn between Perrigo's recent rebound and the unresolved concerns in the background? Act while the data is fresh and weigh both sides through the 4 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Perrigo?

If Perrigo has sharpened your focus, use that momentum to scan fresh ideas now so you are not chasing opportunities after they move.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.